TNFSF13B and autoimmune disease: Given the contribution of BAFF-driven Th17 cell responses to another Th17 cell-dependent autoimmune disease (CIA), BAFF should be viewed as a favorable candidate therapeutic target in Th17 cell-dependent autoimmune diseases.